OSCR

Stereoselective effects of nicotine enantiomers on the gut-brain axis and neuroinflammation in a mouse model of Parkinson's disease.

Overview

Authors: Ruixia Liu1,2,3,4, Yunu Ma3, Yingyan Li1,2,3,4, Xia Gao3,4, Shu Wang1,2,3,4, Lutao Xu3,4, Guanglin Liu1,2,3,4, Huan Chen3,4, Min Ji1,2, Hongwei Hou3,4
  1. Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China
  2. University of Science and Technology of China, Hefei, China
  3. Beijing Life Science Academy, Beijing, China
  4. Key Laboratory of Tobacco Biological Effects, China National Tobacco Quality Supervision & Test Center, Zhengzhou, China
Journal: Frontiers in aging neuroscience, volume 18, article 1823372
Dates: received 5 March 2026; accepted 27 April 2026; published online 13 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fnagi.2026.1823372 · PMID 42212003 · PMCID PMC13212218 · OpenAlex W7161024667
Open access: gold, a free copy (OpenAlex)
Categories: mouse (organism), Parkinson's (population), cellular / molecular (subfield)
Methods: Statistics, Connectivity
Keywords: Akkermansia, gut microbiota, gut-brain axis, MPTP mouse model, neuroinflammation, nicotine enantiomers, Parkinson’s disease, stereoselectivity
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 55 references in the paper

Abstract

Introduction: Parkinson’s disease (PD) is characterized by progressive dopaminergic neurodegeneration, neuroinflammation, and emerging evidence of gut microbiota dysbiosis. Although nicotine has been implicated in neuroprotection, whether its enantiomers exert stereoselective effects on the gut-brain axis remains unknown.

Methods: We systematically compared the effects of S-nicotine and R-nicotine in an MPTP-induced mouse model of PD. Motor function, nigrostriatal dopaminergic neuronal loss, neuroinflammatory responses, intestinal barrier integrity, and gut microbiota composition were assessed.

Results: Both enantiomers ameliorated motor deficits, attenuated nigrostriatal dopaminergic neuronal loss, and suppressed neuroinflammatory responses, yet exhibited markedly different efficacy profiles. S-nicotine produced robust neuroprotection at a lower effective dose (1 mg/kg), associated with improved motor performance, reduced central and peripheral inflammation, preservation of intestinal barrier integrity, and coordinated remodeling of the gut microbiota characterized by enrichment of Akkermansiaceae (notably Akkermansia). In contrast, R-nicotine required a higher dose (3 mg/kg) to achieve comparable neuroprotection and induced weaker and more heterogeneous microbiota alterations. Correlation analyses further revealed that S-nicotine-associated enrichment of Akkermansia was closely linked to improvements in motor function, reduced inflammatory status, and enhanced intestinal integrity.

Discussion: These findings demonstrate pronounced stereoselective and dose-dependent effects of nicotine enantiomers on neuroimmune modulation and identify gut microbiota remodeling as a functionally relevant correlate of nicotine-mediated neuroprotection in PD. Our results highlight the therapeutic potential of targeting the microbiota-gut-brain axis through chiral interventions and support S-nicotine as a promising candidate for neuroprotective strategies in aging-related neurodegenerative disorders.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The datasets presented in this study are available in online repositories. The raw 16S rRNA sequencing data have been deposited in the NCBI BioProject database under accession number PRJNA1398440 (https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1398440). All other data supporting the findings of this study are available from the corresponding author upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added National Natural Science Foundation of China

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 10 authors, 8 keywords, 55 references.

Cite

This paper

Liu, R., Ma, Y., Li, Y., Gao, X., Wang, S., Xu, L., Liu, G., Chen, H., Ji, M., & Hou, H. (2026). Stereoselective effects of nicotine enantiomers on the gut-brain axis and neuroinflammation in a mouse model of Parkinson's disease. Frontiers in aging neuroscience, 18, 1823372. https://doi.org/10.3389/fnagi.2026.1823372

BibTeX

@article{liu2026stereoselective,
author = {Liu, Ruixia and Ma, Yunu and Li, Yingyan and Gao, Xia and Wang, Shu and Xu, Lutao and Liu, Guanglin and Chen, Huan and Ji, Min and Hou, Hongwei},
title = {{Stereoselective effects of nicotine enantiomers on the gut-brain axis and neuroinflammation in a mouse model of Parkinson's disease}},
journal = {Frontiers in aging neuroscience},
year = {2026},
month = may,
volume = {18},
pages = {1823372},
publisher = {Frontiers Media SA},
issn = {1663-4365},
doi = {10.3389/fnagi.2026.1823372},
url = {https://doi.org/10.3389/fnagi.2026.1823372},
pmid = {42212003},
pmcid = {PMC13212218}
}

RIS

TY - JOUR
AU - Liu, Ruixia
AU - Ma, Yunu
AU - Li, Yingyan
AU - Gao, Xia
AU - Wang, Shu
AU - Xu, Lutao
AU - Liu, Guanglin
AU - Chen, Huan
AU - Ji, Min
AU - Hou, Hongwei
TI - Stereoselective effects of nicotine enantiomers on the gut-brain axis and neuroinflammation in a mouse model of Parkinson's disease
T2 - Frontiers in aging neuroscience
J2 - Front Aging Neurosci
PY - 2026
DA - 2026/05/13
VL - 18
SP - 1823372
SN - 1663-4365
PB - Frontiers Media SA
DO - 10.3389/fnagi.2026.1823372
UR - https://doi.org/10.3389/fnagi.2026.1823372
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fnagi.2026.1823372",
"type": "article-journal",
"title": "Stereoselective effects of nicotine enantiomers on the gut-brain axis and neuroinflammation in a mouse model of Parkinson's disease",
"container-title": "Frontiers in aging neuroscience",
"author": [
{
"family": "Liu",
"given": "Ruixia"
},
{
"family": "Ma",
"given": "Yunu"
},
{
"family": "Li",
"given": "Yingyan"
},
{
"family": "Gao",
"given": "Xia"
},
{
"family": "Wang",
"given": "Shu"
},
{
"family": "Xu",
"given": "Lutao"
},
{
"family": "Liu",
"given": "Guanglin"
},
{
"family": "Chen",
"given": "Huan"
},
{
"family": "Ji",
"given": "Min"
},
{
"family": "Hou",
"given": "Hongwei"
}
],
"container-title-short": "Front Aging Neurosci",
"volume": "18",
"page": "1823372",
"DOI": "10.3389/fnagi.2026.1823372",
"PMID": "42212003",
"PMCID": "PMC13212218",
"ISSN": "1663-4365",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fnagi.2026.1823372",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
13
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41531-026-01287-x [code]
Faecalibacterium prausnitzii, depleted in the Parkinson's disease microbiome, improves motor deficits in α-synuclein overexpressing mice.
Journal: NPJ Parkinson's disease
In common: Parkinson's, mouse, cellular / molecular, 6 references
[2] doi:10.1186/s40168-021-01107-9
Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Journal: Microbiome
In common: Parkinson's, mouse, cellular / molecular, 6 references
[3] doi:10.1038/s41531-025-01142-5 [code]
The gut microbiome promotes mitochondrial respiration in the brain of a Parkinson's disease mouse model.
Journal: NPJ Parkinson's disease
In common: Parkinson's, mouse, cellular / molecular, 6 references
[4] doi:10.1007/s10571-023-01319-7
Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent.
Journal: Cellular and molecular neurobiology
In common: Parkinson's, mouse, cellular / molecular, 5 references
[5] doi:10.1371/journal.pone.0296424
Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
Journal: PloS one
In common: Parkinson's, mouse, 5 references
[6] doi:10.3389/fcimb.2026.1806356
Global research trends in enteric nervous system and gut microbiota: a bibliometric analysis (2005-2025).
Journal: Frontiers in cellular and infection microbiology
In common: Parkinson's, cellular / molecular, 5 references
[7] doi:10.1128/spectrum.03379-24
Neuroprotective effects of hypoactive <i>Akkermansia muciniphila</i> in MPTP-induced mouse models of Parkinson's disease.
Journal: Microbiology spectrum
In common: Parkinson's, mouse, 4 references
[8] doi:10.7554/elife.81453
A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice.
Journal: eLife
In common: Parkinson's, mouse, cellular / molecular, 4 references
[9] doi:10.1038/s41531-024-00816-w [code]
α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice.
Journal: NPJ Parkinson's disease
In common: Parkinson's, mouse, cellular / molecular, 4 references
[10] doi:10.1038/s41531-023-00511-2
Gastrointestinal disorders in Parkinson's disease and other Lewy body diseases.
Journal: NPJ Parkinson's disease
In common: Parkinson's, 4 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.